Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-106824
Filing Date
2024-09-16
Accepted
2024-09-16 16:10:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 424b3-dnth-8k-09162024.htm 424B3 47726
2 GRAPHIC img238005119_0.jpg GRAPHIC 173578
  Complete submission text file 0000950170-24-106824.txt   280055
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Filer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-274863 | Film No.: 241301146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)